Teva reaches $4.35 billion settlement in U.S. opioid lawsuits, shares surge
27.07.22|Sophie Shulman and Reuters
Teva is set to pay state and local governments up to $3.7 billion in cash over 13 years plus a contribution of $1.2 billion worth of the opioid overdose reversal drug naloxone